GetTopicDetailResponse(id=8dd31258608, topicName=NCIP, introduction=NCIP, content=null, image=null, comments=3, allHits=1083, url=https://h5.medsci.cn/topic?id=12586, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=102068, tagList=[TagDto(tagId=102068, tagName=NCIP)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1958632, encodeId=c4d1195863268, content=<a href='/topic/show?id=8dd31258608' target=_blank style='color:#2F92EE;'>#NCIP#</a>, objectTitle=吸入性糖皮質(zhì)激素將在PRINCIPLE試驗中作為Covid-19的可能療法進行研究, objectType=article, longId=203847, objectId=d05020384eb6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d05020384eb6, replyNumber=0, likeNumber=118, createdTime=2020-12-23, rootId=0, userName=zhangying8788, userId=68b666, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d05020384eb6, moduleTitle=吸入性糖皮質(zhì)激素將在PRINCIPLE試驗中作為Covid-19的可能療法進行研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d05020384eb6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1958631, encodeId=3b491958631ba, content=<a href='/topic/show?id=8dd31258608' target=_blank style='color:#2F92EE;'>#NCIP#</a>, objectTitle=2019年美國皮膚病學(xué)會會議：Principia Biopharma將宣布皰瘡尋常型試驗的全新數(shù)據(jù), objectType=article, longId=161013, objectId=3a4b1610135a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a4b1610135a, replyNumber=0, likeNumber=102, createdTime=2019-07-06, rootId=0, userName=zhangying8788, userId=68b666, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a4b1610135a, moduleTitle=2019年美國皮膚病學(xué)會會議：Principia Biopharma將宣布皰瘡尋常型試驗的全新數(shù)據(jù), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=3a4b1610135a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1958630, encodeId=ca4c195863072, content=<a href='/topic/show?id=8dd31258608' target=_blank style='color:#2F92EE;'>#NCIP#</a>, objectTitle=Principia 制藥宣布PRN1008獲得FDA孤兒藥認定用于治療免疫性血小板減少性紫癜, objectType=article, longId=151535, objectId=817b1515353f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=817b1515353f, replyNumber=0, likeNumber=90, createdTime=2019-06-15, rootId=0, userName=zhangying8788, userId=68b666, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=817b1515353f, moduleTitle=Principia 制藥宣布PRN1008獲得FDA孤兒藥認定用于治療免疫性血小板減少性紫癜, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=817b1515353f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
